(Q44635627)

4 December 2017

title

Anxiogenic effect of cholecystokinin in the dorsal periaqueductal gray (English)

1 reference

4 December 2017

Anxiogenic Effect of Cholecystokinin in the Dorsal Periaqueductal Gray (English)

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300334

26 March 2024

1 reference

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300334

Francisco Silveira Guimarães

26 March 2024

author

series ordinal

2

object named as

Francisco Silveira Guimarães

1 reference

4 December 2017

author name string

Cristina Ferreira Netto

series ordinal

1

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 January 2004

1 reference

full work available at URL

4 December 2017

https://www.nature.com/articles/1300334.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14583742

http://www.nature.com/articles/1300334.pdf

26 March 2024

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300334

http://www.nature.com/articles/1300334

26 March 2024

1 reference

https://api.crossref.org/works/10.1038/SJ.NPP.1300334

26 March 2024

published in

Neuropsychopharmacology

1 reference

4 December 2017

volume

29

1 reference

4 December 2017

issue

1

1 reference

4 December 2017

page(s)

101-107

1 reference

Functional characteristics of the midbrain periaqueductal gray

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300334

The cholecystokinin hypothesis of panic and anxiety disorders: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300334

The panicogenic effects of cholecystokinin-tetrapeptide are antagonized by L-365,260, a central cholecystokinin receptor antagonist, in patients with panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300334

Fos-like immunoreactivity in the periaqueductal gray of rats exposed to a natural predator

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300334

Anxiolytic effects of CCK-B antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300334

Regional distribution of cholecystokinin messenger RNA in rat brain during development: quantitation and correlation with cholecystokinin immunoreactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300334

Behavioral and c-fos expression changes induced by nitric oxide donors microinjected into the dorsal periaqueductal gray.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300334

Social isolation increases cholecystokinin mRNA in the central nervous system of rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300334

Defensive behavior in rats towards predatory odors: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300334

Stimulation of either cholecystokinin receptor subtype reduces while antagonists potentiate or sensitize a morphine-induced excitatory response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300334

Major biological actions of CCK--a critical evaluation of research findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300334

Anxiolytic effect in the elevated plus-maze of the NMDA receptor antagonist AP7 microinjected into the dorsal periaqueductal grey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300334

Role of cholecystokinin-A and cholecystokinin-B receptors in anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300334

Cholecystokinin antagonists: pharmacological and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300334

Effects of acute and chronic fluoxetine treatments on restraint stress-induced Fos expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300334

Characterization of the effect of cholecystokinin (CCK) on neurons in the periaqueductal gray of the rat: immunocytochemical and in vivo and in vitro electrophysiological studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300334

On the distribution of cholecystokinin B receptors in monkey brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300334

Cholecystokinin and panic disorder--three unsettled questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300334

Short‐term restraint stress and s.c. saline injection alter the tissue levels of substance P and cholecystokinin in the peri‐aqueductal grey and limbic regions of rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300334

Role of benzodiazepine receptors located in the dorsal periaqueductal grey of rats in anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300334

Fear and power-dominance drive motivation: neural representations and pathways mediating sensory and mnemonic inputs, and outputs to premotor structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300334

Neuroanatomical targets of anxiogenic drugs in the hindbrain as revealed by Fos immunocytochemistry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300334

Involvement of different subtypes of cholecystokinin receptors in opioid antinociception in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300334

Involvement of supraspinal and spinal CCK receptors in the modulation of antinociception induced by cold water swimming stress in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300334

Anxiogenic stimuli in the elevated plus-maze.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300334

Genetic variations in CCK₂ receptor in PVG hooded and Sprague-Dawley rats and its mRNA expression on cat exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300334

Blockade of CCK(B) but not CCK(A) receptors before and after the stress of predator exposure prevents lasting increases in anxiety-like behavior: implications for anxiety associated with posttraumatic stress disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300334

7 January 2021

A cholecystokinin-mediated pathway to the paraventricular thalamus is recruited in chronically stressed rats and regulates hypothalamic-pituitary-adrenal function.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300334

7 January 2021

CCK receptor antagonists in animal models of anxiety: comparison between exploration tests, conflict procedures and a model based on defensive behaviours.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300334

7 January 2021

Brain cholecystokinin tetrapeptide levels are increased in a rat model of anxiety.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300334

7 January 2021

Identifiers

1 reference

4 December 2017

1 reference